HPS Pharmacies wish to give notice that Medicianz Healthcare, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Medsurge Mupirocin Nasal Ointment as follows:
Medsurge Mupirocin Nasal Ointment
Mupirocin (as calcium) 2% (5g tube)
The manufacturer is recalling one batch due to an out-of-specification result found during routine annual stability testing. The batch being recalled has subsequently been tested and passed specification. Therefore, there is no immediate impact on product quality.
Affected batch number: 072106.1
Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Medsurge Healthcare on 1300 788 261 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates